Evidence map›Paper›PMID 33127907›Full record

ArticleNature communications2020

SDE2 integrates into the TIMELESS-TIPIN complex to protect stalled replication forks.

Julie Rageul, Jennifer J Park, Ping Ping Zeng, Eun-A Lee, Jihyeon Yang, Sunyoung Hwang, Natalie Lo, Alexandra S Weinheimer, Orlando D Schärer, Jung-Eun Yeo and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julie RageulDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA.ORCID 0000-0002-2912-7043
Jennifer J ParkDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA.
Ping Ping ZengDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA.
Eun-A LeeCenter for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea.
Jihyeon YangCenter for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea.
Sunyoung HwangCenter for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea.
Natalie LoDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA.
Alexandra S WeinheimerDepartment of Biochemistry and Cell Biology, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA.
Orlando D SchärerCenter for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea.
Jung-Eun YeoCenter for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea. jyeo@ibs.re.kr.
Hyungjin KimDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA. hyungjin.kim@stonybrook.edu.ORCID 0000-0003-1913-6373

Funding

Chemical Biology Training InterfaceT32GM136572 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI ELIZABETH M BOON, Jessica Chuang Seeliger · 2020 to 2026
$2.9M
Proteolytic control of DNA interstrand cross-link repair and genome integrityR01CA218132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI KIM, HYUNGJIN · 2018 to 2022
$1.8M
NCI NIH HHS R01 CA218132NIGMS NIH HHS T32 GM136572
6 · The paper itself

Abstract

Protecting replication fork integrity during DNA replication is essential for maintaining genome stability. Here, we report that SDE2, a PCNA-associated protein, plays a key role in maintaining active replication and counteracting replication stress by regulating the replication fork protection complex (FPC). SDE2 directly interacts with the FPC component TIMELESS (TIM) and enhances its stability, thereby aiding TIM localization to replication forks and the coordination of replisome progression. Like TIM deficiency, knockdown of SDE2 leads to impaired fork progression and stalled fork recovery, along with a failure to activate CHK1 phosphorylation. Moreover, loss of SDE2 or TIM results in an excessive MRE11-dependent degradation of reversed forks. Together, our study uncovers an essential role for SDE2 in maintaining genomic integrity by stabilizing the FPC and describes a new role for TIM in protecting stalled replication forks. We propose that TIM-mediated fork protection may represent a way to cooperate with BRCA-dependent fork stabilization.

Indexed as

Cell Cycle ProteinsCheckpoint Kinase 1Chromosome StructuresDNA-Binding ProteinsDNA DamageDNA RepairDNA ReplicationGene Expression RegulationGene Knockdown TechniquesGenomic InstabilityHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMRE11 Homologue ProteinNuclear ProteinsPhosphorylationCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsMRE11 Homologue ProteinMRE11 protein, humanNuclear ProteinsSDE2 protein, humanTIMELESS protein, humanTipin protein, human

Identifiers

PMID33127907
PMCPMC7603486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.